These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 19159013)

  • 1. S100A7, a novel Alzheimer's disease biomarker with non-amyloidogenic alpha-secretase activity acts via selective promotion of ADAM-10.
    Qin W; Ho L; Wang J; Peskind E; Pasinetti GM
    PLoS One; 2009; 4(1):e4183. PubMed ID: 19159013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platelet amyloid precursor protein processing: a bio-marker for Alzheimer's disease.
    Tang K; Hynan LS; Baskin F; Rosenberg RN
    J Neurol Sci; 2006 Jan; 240(1-2):53-8. PubMed ID: 16256140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ADAM10 as a biomarker for Alzheimer's disease: a study with Brazilian elderly.
    Manzine PR; de França Bram JM; Barham EJ; do Vale Fde A; Selistre-de-Araújo HS; Cominetti MR; Iost Pavarini SC
    Dement Geriatr Cogn Disord; 2013; 35(1-2):58-66. PubMed ID: 23306532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of peroxisome proliferator-activated receptor α stimulates ADAM10-mediated proteolysis of APP.
    Corbett GT; Gonzalez FJ; Pahan K
    Proc Natl Acad Sci U S A; 2015 Jul; 112(27):8445-50. PubMed ID: 26080426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activated protein C inhibits amyloid β production via promoting expression of ADAM-10.
    Li B; Yu D; Xu Z
    Brain Res; 2014 Jan; 1545():35-44. PubMed ID: 24333930
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential late-onset Alzheimer's disease-associated mutations in the ADAM10 gene attenuate {alpha}-secretase activity.
    Kim M; Suh J; Romano D; Truong MH; Mullin K; Hooli B; Norton D; Tesco G; Elliott K; Wagner SL; Moir RD; Becker KD; Tanzi RE
    Hum Mol Genet; 2009 Oct; 18(20):3987-96. PubMed ID: 19608551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PGC-1alpha expression decreases in the Alzheimer disease brain as a function of dementia.
    Qin W; Haroutunian V; Katsel P; Cardozo CP; Ho L; Buxbaum JD; Pasinetti GM
    Arch Neurol; 2009 Mar; 66(3):352-61. PubMed ID: 19273754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet a disintegrin and metallopeptidase 10 expression correlates with clock drawing test scores in Alzheimer's disease.
    Manzine PR; Barham EJ; Vale FA; Selistre-de-Araújo HS; Pavarini SC; Cominetti MR
    Int J Geriatr Psychiatry; 2014 Apr; 29(4):414-20. PubMed ID: 23970375
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ADAM10 gene expression in the blood cells of Alzheimer's disease patients and mild cognitive impairment subjects.
    Manzine PR; Marcello E; Borroni B; Kamphuis W; Hol E; Padovani A; Nascimento CC; de Godoy Bueno P; Assis Carvalho Vale F; Iost Pavarini SC; Di Luca M; Cominetti MR
    Biomarkers; 2015; 20(3):196-201. PubMed ID: 26220620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ADAM10 Plasma and CSF Levels Are Increased in Mild Alzheimer's Disease.
    Pereira Vatanabe I; Peron R; Mantellatto Grigoli M; Pelucchi S; De Cesare G; Magalhães T; Manzine PR; Figueredo Balthazar ML; Di Luca M; Marcello E; Cominetti MR
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33670873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells.
    Panmanee J; Nopparat C; Chavanich N; Shukla M; Mukda S; Song W; Vincent B; Govitrapong P
    J Pineal Res; 2015 Oct; 59(3):308-20. PubMed ID: 26123100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [alpha]-Secretase ADAM10 as well as [alpha]APPs is reduced in platelets and CSF of Alzheimer disease patients.
    Colciaghi F; Borroni B; Pastorino L; Marcello E; Zimmermann M; Cattabeni F; Padovani A; Di Luca M
    Mol Med; 2002 Feb; 8(2):67-74. PubMed ID: 12080182
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Huperzine A regulates amyloid precursor protein processing via protein kinase C and mitogen-activated protein kinase pathways in neuroblastoma SK-N-SH cells over-expressing wild type human amyloid precursor protein 695.
    Peng Y; Lee DY; Jiang L; Ma Z; Schachter SC; Lemere CA
    Neuroscience; 2007 Dec; 150(2):386-95. PubMed ID: 17945434
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alpha-secretase as a therapeutic target.
    Fahrenholz F
    Curr Alzheimer Res; 2007 Sep; 4(4):412-7. PubMed ID: 17908044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apolipoprotein E-mediated Modulation of ADAM10 in Alzheimer's Disease.
    Shackleton B; Crawford F; Bachmeier C
    Curr Alzheimer Res; 2017; 14(6):578-585. PubMed ID: 28164773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of ADAM10 in Alzheimer's Disease.
    Yuan XZ; Sun S; Tan CC; Yu JT; Tan L
    J Alzheimers Dis; 2017; 58(2):303-322. PubMed ID: 28409746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations in the Expression of Amyloid Precursor Protein Cleaving Enzymes mRNA in Alzheimer Peripheral Blood.
    Wongchitrat P; Pakpian N; Kitidee K; Phopin K; Dharmasaroja PA; Govitrapong P
    Curr Alzheimer Res; 2019; 16(1):29-38. PubMed ID: 30411686
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-144 is regulated by activator protein-1 (AP-1) and decreases expression of Alzheimer disease-related a disintegrin and metalloprotease 10 (ADAM10).
    Cheng C; Li W; Zhang Z; Yoshimura S; Hao Q; Zhang C; Wang Z
    J Biol Chem; 2013 May; 288(19):13748-61. PubMed ID: 23546882
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Processing of the platelet amyloid precursor protein in the mild cognitive impairment (MCI).
    Bermejo-Bescós P; Martín-Aragón S; Jiménez-Aliaga K; Benedí J; Felici E; Gil P; Ribera JM; Villar AM
    Neurochem Res; 2013 Jul; 38(7):1415-23. PubMed ID: 23575575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thioredoxin-80 is a product of alpha-secretase cleavage that inhibits amyloid-beta aggregation and is decreased in Alzheimer's disease brain.
    Gil-Bea F; Akterin S; Persson T; Mateos L; Sandebring A; Avila-Cariño J; Gutierrez-Rodriguez A; Sundström E; Holmgren A; Winblad B; Cedazo-Minguez A
    EMBO Mol Med; 2012 Oct; 4(10):1097-111. PubMed ID: 22933306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.